Vega, P.
Huguet, J. M.
Gómez, E.
Rubio, S.
Suarez, P.
Vera, M. I.
Paredes, J. M.
Hernández-Camba, A.
Plaza, R.
Mañosa, M.
Pajares, R.
Sicilia, B.
Madero, L.
Kolterer, S.
Leitner, C.
Heatta-Speicher, T.
Michelena, N.
Santos de Lamadrid, R.
Dignass, A.
Gomollón, F. http://orcid.org/0000-0003-0076-3529
Funding for this research was provided by:
AbbVie
Universidad de Zaragoza
Article History
Received: 28 July 2023
Accepted: 10 October 2023
First Online: 13 January 2024
Declarations
:
: Pablo Vega has received honoraria as speaker from Janssen, Abbvie, Takeda and MSD; and participated in advisory panels for Takeda and Abbvie. JM Huguet reports educational activities, research projects, scientific meetings, advisory boards sponsored by MSD, Ferring, Abbvie, Janssen, Sandoz, Kern Pharma, Faes Farma, and Takeda. Elena Gómez has received honoraria as speaker from Janssen, Abbvie, Takeda, Ferring, Falk, Adacyte Therapeutics and Casen Recordati. JM Paredes reports educational activities, research projects, scientific meetings or advisory boards sponsored by MSD, Ferring, Abbvie, Janssen, Kern Pharma and Takeda. Rocío Plaza has received honoraria as speaker from Janssen, Abbvie and Takeda and travel expenses from Ferring, Dr.FALK, Pfizer and Tillots Pharma. “Saioa Rubio reports educational activities and has received honoraria as speaker from Abbvie, Ferring, Jassen, Takeda and Tillots. Alejandro Hernández-Camba has served as a speaker or has received research funding from AbbVie, Janssen, Pfizer, Galapagos, Faes-Farma, Ferring, Kern Pharama, Takeda, Tillots. Patricia Suarez has received honoraria as speaker from Abbvie, Janssen, Gebro pharma, Takeda, Abbott, Ferring, Tillotts y Falk pharma. Isabel Vera has received honoraria as speaker, consultant and advisory member for MSD, Abbvie, Pfizer, Ferring, Shire Pharmaceuticals, Takeda, Tillots, Janssen Pharmaceuticals and Galapagos. Ramón Pajares has received honoraria as speaker from Takeda and travel expenses from Takeda and Janssen. Míriam Mañosa has served as a speaker, consultant and advisory member for or has received research funding from AbbVie, Janssen, MSD, Pfizer, Galapagos, Faes-Farma, Takeda, Tillots. Beatriz Sicilia reports educational activities, investigational activities and scientific meetings or advisory boards sponsored by Abbvie, FAES, Chiesi, Dr. Falk, MSD, Tillots Pharma, Khern Pharma, Janssen, Pfizer y Takeda. Lucía Madero has received honoraria as speaker from Abbvie. Stefanie Kolterer was employee of AbbVie and is currently employee at GSK and may own stock/options. Tobias Heatta-Speicher, Claudia Leitner, Naiara Michelena, Regina Santos de Lamadrid are employees of AbbVie and may own stock/options. A. Dignass has received fees for participation in clinical trials and for review activities, such as data monitoring boards, statistical analysis and endpoint committees from Abivax, AbbVie, Arena, Celgene/Bristol Myers Squibb, Falk, Gilead, Janssen and Pfizer; consultancy fees from AbbVie, Amgen, Biogen, Boehringer-Ingelheim, Celgene/Bristol Myers Squibb, Celltrion, Falk, Ferring, Fresenius Kabi, Galapagos, Gilead, Janssen, Lilly, MSD, Pfizer, Pharmacosmos, Roche/Genentech, Sandoz/Hexal, Takeda, Tillotts and Vifor; and payment for lectures including service on speaker bureaus from AbbVie, Amgen, Biogen, Celltrion, Falk Foundation, Ferring, Gilead/Galapagos, Janssen, Lilly, MSD, Pharmacosmos, Pfizer, Takeda, Tillotts and Vifor. Fernando Gomollón has received honoraria as speaker from Janssen, AbbVie, Takeda and MSD; and participated in advisory panels for Faes-Farma and AbbVie.